Visse R - Search Results

1

Structure and function of matrix metalloproteinases and TIMPs.

Nagase H, Visse R, Murphy G. Nagase H, et al. Among authors: visse r. Cardiovasc Res. 2006 Feb 15;69(3):562-73. doi: 10.1016/j.cardiores.2005.12.002. Epub 2006 Jan 5. Cardiovasc Res. 2006. PMID: 16405877 Review.

2

MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1.

Yamamoto K, Okano H, Miyagawa W, Visse R, Shitomi Y, Santamaria S, Dudhia J, Troeberg L, Strickland DK, Hirohata S, Nagase H. Yamamoto K, et al. Among authors: visse r. Matrix Biol. 2016 Dec;56:57-73. doi: 10.1016/j.matbio.2016.03.007. Epub 2016 Apr 12. Matrix Biol. 2016. PMID: 27084377 Free PMC article.

3

Crystal structure of an active form of human MMP-1.

Iyer S, Visse R, Nagase H, Acharya KR. Iyer S, et al. Among authors: visse r. J Mol Biol. 2006 Sep 8;362(1):78-88. doi: 10.1016/j.jmb.2006.06.079. Epub 2006 Aug 4. J Mol Biol. 2006. PMID: 16890240 Free PMC article.

4

Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.

Lim NH, Kashiwagi M, Visse R, Jones J, Enghild JJ, Brew K, Nagase H. Lim NH, et al. Among authors: visse r. Biochem J. 2010 Oct 1;431(1):113-22. doi: 10.1042/BJ20100725. Biochem J. 2010. PMID: 20645923 Free PMC article.

5

Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.

Makareeva E, Han S, Vera JC, Sackett DL, Holmbeck K, Phillips CL, Visse R, Nagase H, Leikin S. Makareeva E, et al. Among authors: visse r. Cancer Res. 2010 Jun 1;70(11):4366-74. doi: 10.1158/0008-5472.CAN-09-4057. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460529 Free PMC article.

6

Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1.

Manka SW, Carafoli F, Visse R, Bihan D, Raynal N, Farndale RW, Murphy G, Enghild JJ, Hohenester E, Nagase H. Manka SW, et al. Among authors: visse r. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12461-6. doi: 10.1073/pnas.1204991109. Epub 2012 Jul 3. Proc Natl Acad Sci U S A. 2012. PMID: 22761315 Free PMC article.

7

Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.

Doherty CM, Visse R, Dinakarpandian D, Strickland DK, Nagase H, Troeberg L. Doherty CM, et al. Among authors: visse r. J Biol Chem. 2016 Oct 14;291(42):22160-22172. doi: 10.1074/jbc.M116.733261. Epub 2016 Aug 31. J Biol Chem. 2016. PMID: 27582494 Free PMC article.

8

The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage.

Howes JM, Bihan D, Slatter DA, Hamaia SW, Packman LC, Knauper V, Visse R, Farndale RW. Howes JM, et al. Among authors: visse r. J Biol Chem. 2014 Aug 29;289(35):24091-101. doi: 10.1074/jbc.M114.583443. Epub 2014 Jul 9. J Biol Chem. 2014. PMID: 25008319 Free PMC article.

9

Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.

Stura EA, Visse R, Cuniasse P, Dive V, Nagase H. Stura EA, et al. Among authors: visse r. FASEB J. 2013 Nov;27(11):4395-405. doi: 10.1096/fj.13-233601. Epub 2013 Aug 2. FASEB J. 2013. PMID: 23913860 Free PMC article.

10

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Visse R, Nagase H. Visse R, et al. Circ Res. 2003 May 2;92(8):827-39. doi: 10.1161/01.RES.0000070112.80711.3D. Circ Res. 2003. PMID: 12730128 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results